Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 22
2020
|
Flagship Ventures Fund Iv General Partner LLC Director |
SELL
Open market or private sale
|
Indirect |
500,000
-0.78%
|
$34,500,000
$69.81 P/Share
|
|
May 21
2020
|
Flagship Ventures Fund Iv General Partner LLC Director |
SELL
Open market or private sale
|
Indirect |
500,000
-0.26%
|
$34,500,000
$69.36 P/Share
|
|
May 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
12,558
-0.08%
|
$879,060
$70.0 P/Share
|
|
May 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,186
-0.06%
|
$293,020
$70.0 P/Share
|
|
May 20
2020
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
64,000
-100.0%
|
$4,480,000
$70.0 P/Share
|
|
May 20
2020
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
64,000
+50.0%
|
$896,000
$14.85 P/Share
|
|
May 19
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
125,044
-100.0%
|
$9,753,432
$78.16 P/Share
|
|
May 19
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,044
+48.68%
|
$1,500,528
$12.21 P/Share
|
|
May 18
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
241,000
-1.63%
|
$19,762,000
$82.14 P/Share
|
|
May 18
2020
|
Lorence H. Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
241,000
+7.55%
|
$3,133,000
$13.22 P/Share
|
|
May 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.46%
|
$717,990
$65.5 P/Share
|
|
May 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,577
-0.02%
|
-
|
|
May 15
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.41%
|
$1,300,000
$65.37 P/Share
|
|
May 13
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
127,500
-46.37%
|
$8,160,000
$64.23 P/Share
|
|
May 13
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
127,500
+50.0%
|
$1,530,000
$12.21 P/Share
|
|
May 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.05%
|
$315,000
$63.94 P/Share
|
|
May 12
2020
|
Elizabeth G Nabel Director |
SELL
Open market or private sale
|
Direct |
30,000
-67.65%
|
$1,980,000
$66.0 P/Share
|
|
May 12
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
125,044
-39.43%
|
$8,127,860
$65.01 P/Share
|
|
May 12
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,044
+50.0%
|
$1,500,528
$12.21 P/Share
|
|
May 12
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
241,000
-2.92%
|
$15,665,000
$65.0 P/Share
|
|
May 12
2020
|
Lorence H. Kim Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
241,000
+7.24%
|
$2,651,000
$11.56 P/Share
|
|
May 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.05%
|
$320,000
$64.83 P/Share
|
|
May 12
2020
|
Stephane Bancel Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
55,568
+0.82%
|
-
|
|
May 11
2020
|
Flagship Ventures Fund Iv General Partner LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
12,281,179
-48.84%
|
-
|
|
May 11
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,127
-0.06%
|
$597,493
$59.57 P/Share
|
|
May 11
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,376
-0.05%
|
$199,184
$59.57 P/Share
|
|
May 08
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.26%
|
$618,576
$56.11 P/Share
|
|
May 05
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,770
-100.0%
|
$238,500
$50.48 P/Share
|
|
May 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
24,093
-0.64%
|
$1,156,464
$48.7 P/Share
|
|
May 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,349
-0.07%
|
$208,752
$48.7 P/Share
|
|
May 01
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
25,000
-58.29%
|
$1,200,000
$48.32 P/Share
|
|
May 01
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$300,000
$12.21 P/Share
|
|
Apr 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.72%
|
$519,162
$47.15 P/Share
|
|
Apr 24
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-67.7%
|
$470,000
$47.15 P/Share
|
|
Apr 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$245,000
$49.12 P/Share
|
|
Apr 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.06%
|
$245,000
$49.1 P/Share
|
|
Apr 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
12,807
-0.08%
|
$576,315
$45.0 P/Share
|
|
Apr 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,269
-0.06%
|
$192,105
$45.0 P/Share
|
|
Apr 17
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.34%
|
$508,116
$46.3 P/Share
|
|
Apr 17
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-40.37%
|
$480,000
$48.81 P/Share
|
|
Apr 15
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,936
-0.04%
|
-
|
|
Apr 15
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.32%
|
$720,000
$36.5 P/Share
|
|
Apr 15
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
23,403
-55.59%
|
$842,508
$36.91 P/Share
|
|
Apr 15
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,403
+50.0%
|
$280,836
$12.21 P/Share
|
|
Apr 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
20,462
-0.59%
|
$654,784
$32.0 P/Share
|
|
Apr 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,139
-0.05%
|
$100,448
$32.0 P/Share
|
|
Apr 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.25%
|
$320,000
$32.62 P/Share
|
|
Apr 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-28.76%
|
$320,000
$32.0 P/Share
|
|
Apr 06
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
300
-100.0%
|
$10,500
$35.13 P/Share
|
|
Apr 06
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+50.0%
|
$3,600
$12.21 P/Share
|